(19)
(11) EP 1 370 585 A2

(12)

(88) Date of publication A3:
17.04.2003

(43) Date of publication:
17.12.2003 Bulletin 2003/51

(21) Application number: 02712956.8

(22) Date of filing: 05.03.2002
(51) International Patent Classification (IPC)7: C07K 14/705, C12N 15/85, C12N 15/861, C12N 15/10, C12N 15/12, C07K 16/28, C12Q 1/68, A61K 48/00, A61K 38/16, G01N 33/50, A61L 27/38
(86) International application number:
PCT/EP0203/320
(87) International publication number:
WO 0208/5943 (31.10.2002 Gazette 2002/44)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 05.03.2001 US 272759 P

(71) Applicants:
  • Aventis Pharma S.A.
    92160 Antony (FR)
  • The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services
    Washington, D.C. 20201 (US)

(72) Inventors:
  • ROSIER-MONTUS, Marie-Françoise
    F-92160 Antony (FR)
  • PRADES, Catherine
    F-94320 Thiais (FR)
  • ARNOULD-REGUIGNE, Isabelle
    F-94430 Chennevieres Sur Marne (FR)
  • DENEFLE, Patrice
    F-94100 Saint Maur (FR)
  • DEAN, Michael
    Frederick, MD (US)
  • ALLIKMETS, Rando
    Nonroe, NY 10950 (US)

(74) Representative: Bouvet, Philippe 
Aventis Pharma S.A.20, Avenue Raymond Aron
92165 Antony Cedex
92165 Antony Cedex (FR)

   


(54) NUCLEIC ACIDS OF THE HUMAN ABCC12 GENE, VECTORS CONTAINING SUCH NUCLEIC ACIDS AND USES THEREOF